Invited commentary: recommendation for a north american pediatric patch test series

Sharon E Jacob1, Shehla Admani, Elise M Herro

  • 1University of California-Rady Children's Hospital, 8010 Frost Street, Suite 602, San Diego, CA, 92123, USA, sjacob@contactderm.net.

Insights

A new 20-allergen North American pediatric series was developed for screening children aged 6-12 with suspected allergic contact dermatitis. This standardized approach addresses the lack of consensus in pediatric patch testing.

Area of Science:

  • Dermatology
  • Pediatric Allergy
  • Immunology

Background:

  • Pediatric allergic contact dermatitis (ACD) is increasingly recognized.
  • A lack of standardized patch testing guidelines exists for children.
  • Accurate diagnosis of ACD in pediatric populations is challenging.

Purpose of the Study:

  • To establish a minimum basic 20-allergen North American pediatric series.
  • To provide a standardized screening tool for children with suspected contact allergy.
  • To improve the diagnostic accuracy of ACD in pediatric patients.

Main Methods:

  • Development of a 20-allergen series.
  • Targeting children aged 6-12 years.
  • Focus on screening for suspected contact allergy.

Main Results:

  • A defined 20-allergen series for pediatric screening has been proposed.
  • This series aims to standardize patch testing in children.
  • Facilitates the identification of common allergens in pediatric ACD.

Conclusions:

  • The proposed 20-allergen series offers a foundational tool for pediatric patch testing.
  • Standardization is crucial for the accurate diagnosis and management of pediatric allergic contact dermatitis.
  • Further research may refine and expand this pediatric series.